Neoplasm, Residual - 23 Studies Found

Active, not recruiting : Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
: Leukemia
: 2011-10-24
:
  • Drug: Azacitidine (AZA) Starti
Recruiting : Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
:
  • Leukemia
  • Acute Lymphocytic Leukemia

: 2015-05-26
:
  • Drug: Blinatumomab In first in
Completed : Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)
: Acute Lymphoblastic Leukemia
: 2007-11-19
: Biological: Blinatumomab (MT103) Administered by continuous intravenous (CIV) over 4 weeks per cycle
<<< Previous